MYCN and neuroblastoma: Unlike NXS2, the 9464D model has similar characteristics to human HR-NB, with a low tumor mutation burden, overexpression of MYCN, and aberrant expression of MHC-I, whereby only about 25% of 9464D are capable of MHC-I induction upon IFN-γ stimulation [9,18].